Antibiotic Resistance: Challenges and Opportunities, An Issue of Infectious Disease Clinics of North America (Volume 30-2) (The Clinics: Internal Medicine, Volume 30-2) - Image 1

£73.97

Elsevier Antibiotic Resistance: Challenges and Opportunities, An Issue of Infectious Disease Clinics of North America (Volume 30-2) (The Clinics: Internal Medicine, Volume 30-2)

Name: Antibiotic Resistance: Challenges and Opportunities, An Issue of Infectious Disease Clinics of North America (Volume 30-2) (The Clinics: Internal Medicine, Volume 30-2)
Brand: Elsevier
Price: 73.81 GBP
Availability: InStock

Public Health

Price History & Forecast

Last 71 days • 71 data points (No recent data available)

Historical

Generating forecast...

Price Distribution

Price distribution over 71 days • 1 price levels

Days at Price

Price Analysis

Most common price: £74 (71 days, 100.0%)

Price range: £74 - £74

Price levels: 1 different prices over 71 days

Description

For many years, physicians and the public assumed that the discovery of new antimicrobial agents would outpace the ability of bacteria to mutate and develop drug resistance. Yet the development of new antibiotics has not kept up with bacterial evolution, especially since the late 1990's. At that time a multitude of pharmaceutical companies abandoned antibiotic research because of strong economic disincentives. For example, it is challenging for these companies to recuperate the investment (typically in the hundreds of millions of dollars) made in developing a new antibiotic, which is typically prescribed for a few days, compared to drugs that treat chronic conditions like heart disease or mental illness. This situation has led the U.S. federal government to take a more active lead in addressing antibiotic resistance. Recently, the White House announced an action plan that includes improving surveillance, developing better diagnostic tools, accelerating drug development, and improving global coordination of antibiotic resistance issues. Equally important is the $1.2 billion dollars that has been pledged to fund these efforts. While we await the implementation of new policies, this issue of Infectious Disease Clinics of North America brings together leading authorities in the field of antibiotic resistance who discuss current issues including antibiotic stewardship, the changing role of the microbiology laboratory in determining antibiotic resistance in gram-negative pathogens, the continuing spread of metallo-ß-lactamases, ESBLs and KPCs, antibiotic options for treating resistant gram-negative infections such as colistin and tigecycline, resistance mechanisms and new treatment options for Mycobacterium tuberculosis, emerging resistance mechanisms in aminoglycosides, issues with antibiotic resistance in immunocompromised patients, new ß-lactamase inhibitors in the clinic, and resistance in VRE and Staphylococcus aureus. Additionally, combination therapy for resistant gram-negative infections has been advocated by some authorities and the advantages and disadvantages of this strategy will be reviewed.

Product Specifications

Brand: Elsevier
Format: hardcover
ASIN: 0323446183
Category: Books > Subjects > Health, Family & Lifestyle > Medical & Healthcare Practitioners > General Medical Issues > Public Health
Domain: Amazon UK
Release Date: 28 June 2016
Listed Since: 25 November 2015

Barcode

No barcode data available

Elsevier Antibiotic Resistance: Challenges and Opportunities, An Issue of Infectious Disease Clinics of North America (Volume 30-2) (The Clinics: Internal Medicine, Volume 30-2)

Price History & Forecast

Price Distribution

Price Analysis

Description

Product Specifications

Barcode

Similar Products You Might Like

The Ongoing Challenge of Antimicrobial Resistance, An Issue of Infectious Disease Clinics of North America: Volume 34-4 (The Clinics: Internal Medicine, Volume 34-4)

Immunomodulators and Combinatorial Approaches to Tackle Klebsiella

Antimicrobial Drug Resistance: Mechanisms of Drug Resistance, Volume 1 (Infectious Disease)

Antimicrobial Drug Resistance: Clinical and Epidemiological Aspects, Volume 2 (Infectious Disease)

Bacterial Resistance to Antimicrobials

Bacterial Resistance to Antimicrobials

Antimicrobial Drug Resistance: Mechanisms of Drug Resistance, Volume 1

Antimicrobial Drug Resistance: Mechanisms of Drug Resistance, Volume 1

Antimicrobial Resistance: Global Challenges and Future Interventions

Antimicrobial Resistance in the 21st Century (Emerging Infectious Diseases of the 21st Century)

Antibiotic Resistance: Causes & Risk Factors, Mechanisms & Alternatives (Pharmacology Research, Safety Testing and Regulation Series)

Management of Antimicrobials in Infectious Diseases: Impact of Antibiotic Resistance

Antibiotics - Therapeutic Spectrum and Limitations (Developments in Microbiology)

Antimicrobial Drug Resistance: Clinical and Epidemiological Aspects, Volume 2

National Strategy & Action Plan for Combating Antibiotic Resistant Bacteria

Springer - Antimicrobials: New and Old Molecules Book

How to Overcome the Antibiotic Crisis: Facts, Challenges, Technologies and Future Perspectives: 398 (Current Topics in Microbiology and Immunology, 398)

How to Overcome the Antibiotic Crisis: Facts, Challenges, Technologies and Future Perspectives: 398 (Current Topics in Microbiology and Immunology, 398)

Antibiotics and Antibiotic Resistance in the Environment

Antimicrobial Resistance and Implications for the 21st Century (Emerging Infectious Diseases of the 21st Century)

Emerging Nanomaterials and Nano-based Drug Delivery Approaches to Combat Antimicrobial Resistance (Micro and Nano Technologies)

Elsevier Nanostructures for Antimicrobial Therapy Book

21st Century Challenges in Antimicrobial Therapy and Stewardship (Frontiers in Anti-Infective Agents)

Clinical and Epidemiological Aspects of Antimicrobial Resistance